Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a structural heart procedure at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell

Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a structural heart procedure at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell
 

Feature | Structural Heart | April 22, 2021
Advice For Hospitals Starting a Structural Heart Program
The resounding success of transcatheter aortic valve replacement (TAVR) has led the creation of hundreds of structural...
read more
The FDA’s market clearance occurred once the agency reviewed EnsiteVascular’s Section 510(k) premarket notification of intent to market the SiteSeal SV device and determined it is substantially equivalent for the indication for use stated: brachial artery closure. Previously, EnsiteVascular received FDA market clearance for SiteSeal SV for radial artery closure.
News | Hemostasis Management | April 21, 2021
FDA Clears SiteSeal SV Vascular Closure Device for the Brachial Arteries
April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market...
read more
Transforming Interventional Cardiology with Structured Reporting using Change Healthcare's cardiovascular information system (CVIS).
Webinar | Cardiovascular Information Systems (CVIS) | April 21, 2021
WEBINAR: Transforming Interventional Cardiology With Structured Reporting
The adoption of structured reporting within cardiology imaging departments is on the rise. Providers recognize the...
read more
Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a transcatheter structural heart procedure in the hybrid lab at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell

Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a transcatheter structural heart procedure in the hybrid lab at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell

Blog | Structural Heart | April 21, 2021
Creating a Structural Heart Program is an Investment in the Future of the Hospital
As a medical technology journalist, a little more than a decade ago I found myself sitting in those late afternoon "...
read more
News | April 20, 2021
North American COVID-19 STEMI Research Reveals High Mortality and Atypical Symptoms
April 20, 2021 – The Minneapolis Heart Institute Foundation (MHIF) announced the first publication of outcomes from the...
read more
The reSept ASD Occluder is the first structural heart occluder with a metal-free, bioresorbable frame. The novel implant is designed to overcome the limitations of current transcatheter occluders. It is hoped the design will reduce the risk of complications associated with the long-term presence of metal in the heart and to preserve future treatment options requiring transseptal intervention.

The reSept ASD Occluder is the first occluder with a metal-free, bioresorbable frame. It is designed to overcome the limitations of current transcatheter occluders by reducing the risk of complications associated with the long-term presence of metal in the heart and to preserve future treatment options requiring transseptal intervention.

News | Structural Heart Occluders | April 20, 2021
Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial
April 20, 2021 — Start-up medical device company atHeart Medical announced it is initiating its U.S. investigational...
read more
The Elixer Dynamx Coronary Bioadaptor Stent technology uses a bioresorbable polymer that dissolves after three months and disconnected joints between numerous stent segments, allowing it to articulate and share to the vessel and movement.

The Elixer Dynamx Coronary Bioadaptor Stent technology uses a bioresorbable polymer that dissolves after three months and disconnected joints between numerous stent segments, allowing it to articulate and shape to the vessel and its movement.

News | Stents | April 14, 2021
First Patient Treated in Elixer Dynamx Coronary Bioadaptor Stent Technology
April, 14, 2021 – Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized...
read more
The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical AcQCross family of universal transseptal crossing devices. This is the only transseptal puncture system specifically engineered to pair and mate seamlessly with Acutus’ own suite of sheaths and with sheaths sold by other manufacturers. 
News | EP Lab | April 14, 2021
FDA Clears Acutus Medical AcQCross Suite of Transseptal Crossing Devices
April 14, 2021 — The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical AcQCross family of universal...
read more
The new generation Abbott TriClip G4 device has gained European and Canadian approvals for transcatheter tricuspid valve repair (TTVR).

The new generation Abbott TriClip G4 device has gained European and Canadian approvals for transcatheter tricuspid valve repair (TTVR). The device is an iteration of the successful MitraClip device used for transcatheter mitral valve repairs. 

News | Structural Heart | April 08, 2021
Abbott Receives CE Mark and Canadian Approval for Next-Generation TriClip Tricuspid Valve Repair Device
April 8, 2021 — Abbott today announced it has received European CE mark and Health Canada authorization this week for...
read more
A reconstructed vessel segment from a cone-beam CT created table side in the cath lab with the Philips Azurion SmartCT software.

A reconstructed vessel segment from a cone-beam CT created table side in the cath lab with the Philips Azurion SmartCT software. 

News | Angiography | April 07, 2021
Philips SmartCT Enables 3D Image Acquisition in the Cath Lab
April 7, 2021 — Philips Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Philips...
read more
Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

News | Stroke | April 07, 2021
Thrombectomy Market Will Grow With Newly Approved Adjustable Stent Retriever
April 7, 2021 — Market research firm GlobalData's new report, Neurovascular Thrombectomy Devices (Neurology Devices),...
read more
Comparison showing platelet adhesion to the surface of various coronary artery drug-eluting stents (DES) in a preclinical study that used aspirin only. Abbott said the Xience stent's fluoropolymer is significantly more anti-thrombotic than other DES.[2] 

Comparison showing platelet adhesion to the surface of various coronary artery drug-eluting stents (DES) in a preclinical study that used aspirin only. Abbott said the Xience stent's fluoropolymer is significantly more anti-thrombotic than other DES.[2] 

News | Stents | April 06, 2021
Abbott’s Xience Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy for High Bleeding Risk Patients
April 6, 2021 — Abbott today announced its Xience stent has received CE mark in Europe for shorter duration of dual...
read more
Videos | Cath Lab | April 02, 2021
VIDEO: Standardizing PCI Through Smart Robotic Procedural Automation
Corindus, a Siemens Healthineers company and a developer of vascular robotics, recently launched a new set of automated...
read more
Videos | Coronavirus (COVID-19) | April 01, 2021
VIDEO: Antithrombotic Prophylaxis in COVID-19 Patients
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an...
read more
Sponsored Content | Case Study | Cardiovascular Information Systems (CVIS) | April 01, 2021
Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in...
read more
© Copyright Wainscot Media. All Rights Reserved.